Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019;50(1):37-47.
doi: 10.1159/000500668. Epub 2019 Jun 5.

Fatigue in Nondialysis Chronic Kidney Disease: Correlates and Association with Kidney Outcomes

Affiliations

Fatigue in Nondialysis Chronic Kidney Disease: Correlates and Association with Kidney Outcomes

L Parker Gregg et al. Am J Nephrol. 2019.

Abstract

Background: Fatigue, although common and associated with outcomes in dialysis-dependent chronic kidney disease (CKD), has not been studied in nondialysis chronic kidney disease (CKD-ND) patients.

Methods: In this longitudinal cohort of 266 outpatients with CKD-ND stages 2-5, we measured self-reported fatigue on 3 scales-Quick Inventory of Depression Symptomatology-Self Report (QIDS-SR16), Beck Depression Inventory-I (BDI-I), and short form 12 health survey (SF-12) questionnaires and evaluated the prespecified composite of progression to dialysis initiation, death, or hospitalization after 12 months. Logistic and linear regression assessed characteristics associated with fatigue. Survival analysis measured associations of fatigue with outcomes.

Results: Mean age was 64.4 ± 12.0 years, and mean estimated glomerular filtration rate (eGFR) was 31.6 ± 16.7 mL/min/1.73 m2. Fatigue was common, with 69.2% reporting fatigue on QIDS-SR16 and 77.7% on BDI-I. Unemployment, comorbidities, use of antidepressant medications, and lower hemoglobin correlated with fatigue. There were 126 outcome events. Participants that reported any versus no fatigue on QIDS-SR16 were more likely to reach the composite, hazard ratio (HR) 1.70 (95% CI 1.11-2.59), which persisted after adjusting for demographics, comorbidities, substance abuse, hemoglobin, albumin, eGFR, and calcium-phosphorus product, HR 1.63 (1.05-2.55). Fatigue severity by the SF-12 was also associated with outcomes independent of demographics, comorbidities, and substance abuse, HR per unit increase 1.18 (1.03-1.35). No association was observed with fatigue on the BDI-I.

Conclusion: Fatigue affected about 2/3 of CKD-ND patients and associated with unemployment, comorbidities, antidepressant medication use, and anemia. Fatigue measured by the QIDS-SR16 and SF-12 independently predicted outcomes in CKD patients. Eliciting the presence of fatigue may be a clinically significant prognostic assessment in CKD patients.

Keywords: Outcomes; Chronic kidney disease; Fatigue; Hospitalization; Mortality.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Prevalence and Severity of Fatigue and Associations with Outcomes. (A) Proportion of participants self-reporting scores of 0, 1, 2, or 3 on the QIDS-SR16 and the BDI-I. Higher scores indicate more severe fatigue. (B) Median (IQR) SF-12 score on a scale of 1 to 6, with higher scores indicating more severe fatigue. (C) Kaplan-Meier curve showing time to composite outcome of all-cause hospitalization, dialysis initiation, or death in participants with any vs. no fatigue on the QIDS-SR16.

References

    1. Jim HS, Sutton SK, Jacobsen PB, Martin PJ, Flowers ME, Lee SJ. Risk factors for depression and fatigue among survivors of hematopoietic cell transplantation. Cancer. 2016;122(8):1290–7. - PMC - PubMed
    1. Bossola M, Vulpio C, Tazza L. Fatigue in chronic dialysis patients. Seminars in dialysis. 2011;24(5):550–5. - PubMed
    1. Barnes S, Gott M, Payne S, Parker C, Seamark D, Gariballa S, et al. Prevalence of symptoms in a community-based sample of heart failure patients. J Pain Symptom Manage. 2006;32(3):208–16. - PubMed
    1. Jhamb M, Liang K, Yabes J, Steel JL, Dew MA, Shah N, et al. Prevalence and correlates of fatigue in chronic kidney disease and end-stage renal disease: are sleep disorders a key to understanding fatigue? American journal of nephrology. 2013;38(6):489–95. - PMC - PubMed
    1. Overman CL, Kool MB, Da Silva JA, Geenen R. The prevalence of severe fatigue in rheumatic diseases: an international study. Clin Rheumatol. 2016;35(2):409–15. - PMC - PubMed

Publication types

MeSH terms